Internal Medicine, Medical Oncology · Waterford, CT
NPI
1487626214
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
196 Parkway South, Suite 303
Waterford, CT, 06385
Phone (860) 443-4455
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
581 services
Medicare patients, 2024
237
Average age 76
Drug cost, 2024
$3.8M
1,051 prescriptions
Company payments, 2025
$178
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Kane was code 99214 (office e&m - established), 298 times for 146 patients. In total Michael J Kane billed 581 services in 14 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 298 | 146 | $72.77 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 75 | $13.57 | $1,303 |
| 99213 Office E&M - Established | Office | 75 | 62 | $41.79 | $3,135 |
| 99204 Office E&M - New | Office | 56 | 56 | $104.84 | $5,871 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $130.02 | $1,560 |
By year: 2022 $29K for 406 services; 2023 $34K for 473 services; 2024 $37K for 581 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Kane prescribed most often to Medicare patients was Abiraterone Acetate, with 353 prescriptions and refills. In total Michael J Kane wrote 1,051 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 353 | 371 | 44 | $1.4M |
| Orgovyx Relugolix | 161 | 189 | 21 | $511K |
| Prednisone Generic | 152 | 330 | 41 | $993 |
| Anastrozole Generic | 38 | 100 | 14 | $764 |
| Eliquis Apixaban | 24 | 48 | Under 11 | $27K |
| Ibrance Palbociclib | 22 | 22 | Under 11 | $350K |
| Nubeqa Darolutamide | 20 | 20 | Under 11 | $274K |
| Imatinib Mesylate Generic | 19 | 19 | Under 11 | $1,428 |
| Lenalidomide Generic | 17 | 17 | Under 11 | $254K |
| Revlimid Lenalidomide | 14 | 14 | Under 11 | $285K |
| Calquence Acalabrutinib Maleate | 12 | 12 | Under 11 | $163K |
| Potassium Chloride Generic | 12 | 24 | Under 11 | $192 |
| Xtandi Enzalutamide | 12 | 14 | Under 11 | $200K |
| Omega-3 Acid Ethyl Esters Generic | 11 | 11 | Under 11 | $35.31 |
| Tamoxifen Citrate Generic | 11 | 28 | Under 11 | $226 |
Brand drugs: 287 claims; generic drugs: 764 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Kane $178 ($178 in general payments such as food, travel and fees) from 6 companies. The largest payer was Sobi, Inc with $32.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.